We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,268.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.316%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,268.00
VCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

25 Jul 2019 07:00

RNS Number : 6379G
Victrex PLC
25 July 2019
 
 

 

 

 

25 July 2019

Victrex plc: Interim Management Statement

'Aero, Energy & Medical growth offset by continued Auto & Electronics weakness'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its Interim Management Statement for the third quarter (Q3) covering the period 1 April to 30 June 2019.

Against very strong comparatives in the Industrial division, the Group saw good growth in Aerospace and Energy, whilst in Medical, we continued to see steady growth. In line with macro-indicators and reflecting wider market performance, Automotive, Electronics and Value-Added-Resellers saw some deterioration during Q3.

 

Q3 also saw the final quarterly comparative from the large Consumer Electronics order, with no volumes sold during Q3 2019.

 

Overall, Q3 Group sales volume was down 21% to 912 tonnes (Q3 2018: 1,161 tonnes), with Group revenue down 14% to £72.0m (Q3 2018: £84.0m). Excluding the large Consumer Electronics order, Q3 Group volume was down 18% and Q3 Group revenue was down 12%. Year to date (to the end of Q3) Group sales volume of 2,811 tonnes is 18% down on the prior year (2018 YTD: 3,417 tonnes), with year to date Group revenue (to the end of Q3) of £217.8m down 13% (2018 YTD: £250.6m).

Mega-programme progress

As part of its Polymer & Parts strategy, Victrex continues to focus on delivering further milestones in its growth pipeline and mega-programmes.

 

The Group has now successfully secured the contract from a major US Automotive manufacturer for a supply of PEEK Gears commencing in FY 2020, building on the existing supply to a major European Automotive manufacturer, with over 10 other development programmes also in place.

 

In Aerospace, following completion of the US manufacturing facility which will support our Loaded Brackets and composite parts, the first prototype parts have now been supplied and we also received our first commercial volume order. In Medical, sales of our PEEK-OPTIMA™ HA Enhanced product continue to track above last year, whilst patient recruitment for the PEEK Knee clinical trial has started, with potential for the first implant before the end of our financial year.

 

Financial position and currency

Victrex has seen no material change to its financial position since 31 March 2019. Currency remains broadly neutral for the second half year, with a small tailwind for FY 2020 based on current rates and with nearly 50% of currency hedges in place.

 

Outlook

With continued weakness in Automotive and Electronics, we remain cautious on these markets, in line with the latest macro-indicators. Whilst we do not expect a recovery in these markets during the final quarter, our own sales and innovation activity, together with slightly better comparatives, offers the opportunity to deliver a more stable performance for the remainder of our financial year.

 

Victrex remains in a good position for the medium to longer term. Through our Polymer & Parts strategy we have the opportunity to drive growth in our core business, further increase our differentiation through our strong pipeline of new products and deliver attractive returns to shareholders. 

 

Analyst & investor conference call

A conference call for analysts & investors will be held today, Thursday 25 July, at 08.00am BST.

Dial in details: +44 (0) 3333 000804 PIN: 82241272#

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Communications +44 (0) 7809 595831

Richard Armitage, Chief Financial Officer +44 (0) 1253 897700

Jakob Sigurdsson, Chief Executive +44 (0) 1253 897700

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of automotive, aerospace, energy (including manufacturing & engineering), electronics and medical. Every day, millions of people use products and applications, which contain our materials - from smart phones, aeroplanes and cars to oil and gas operations and medical devices. With over 40 years' experience, we develop world leading solutions in PEEK and PAEK based polymers, semi-finished and finished parts which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTRIMRTMBITBPL
Date   Source Headline
30th Apr 202011:39 amRNSTotal Voting Rights
17th Apr 202012:04 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSMarket Update
3rd Apr 20207:00 amRNSDirector Declaration
31st Mar 20209:22 amRNSTotal Voting Rights
24th Mar 20202:00 pmRNSDirectorate Change
17th Mar 20203:32 pmRNSHolding(s) in Company
17th Mar 20202:52 pmRNSDirector/PDMR Shareholding
16th Mar 202010:05 amRNSHolding(s) in Company
12th Mar 202012:47 pmRNSDirector/PDMR Shareholding
3rd Mar 20209:49 amRNSDirector/PDMR Shareholding
28th Feb 202011:56 amRNSTotal Voting Rights
20th Feb 20204:50 pmRNSDirector/PDMR Shareholding
13th Feb 20201:59 pmRNSDirector/PDMR Shareholding
6th Feb 20202:34 pmRNSDirector/PDMR Shareholding
6th Feb 20201:20 pmRNSResult of AGM
6th Feb 202010:54 amRNSDirector/PDMR Shareholding
6th Feb 20207:00 amRNSAGM and Q1 Interim Management Statement
5th Feb 20204:22 pmRNSHolding(s) in Company
4th Feb 20203:42 pmRNSHolding(s) in Company
31st Jan 202010:39 amRNSTotal Voting Rights
20th Jan 202010:04 amRNSDirector/PDMR Shareholding
17th Jan 202010:38 amRNSDirector/PDMR Shareholding
13th Jan 20204:06 pmRNSHolding(s) in Company
13th Jan 20208:46 amRNSJoint Venture
3rd Jan 202012:00 pmRNSAnnual Financial Report
31st Dec 20199:00 amRNSTotal Voting Rights
23rd Dec 20191:44 pmRNSHolding(s) in Company
17th Dec 20192:20 pmRNSDirector/PDMR Shareholding
12th Dec 201910:04 amRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSPreliminary Results 2019
2nd Dec 20191:52 pmRNSBlock listing Interim Review
29th Nov 201911:38 amRNSTotal Voting Rights
19th Nov 201911:02 amRNSDirector/PDMR Shareholding
12th Nov 201912:00 pmRNSDirectorate Change
31st Oct 201911:36 amRNSTotal Voting Rights
28th Oct 20191:41 pmRNSHolding(s) in Company
18th Oct 20194:01 pmRNSHolding(s) in Company
18th Oct 20192:20 pmRNSDirector/PDMR Shareholding
16th Oct 201911:04 amRNSAdditional Listing
11th Oct 20194:18 pmRNSHolding(s) in Company
8th Oct 20193:09 pmRNSHolding(s) in Company
7th Oct 20194:06 pmRNSHolding(s) in Company
3rd Oct 20194:18 pmRNSHolding(s) in Company
30th Sep 201911:53 amRNSTotal Voting Rights
18th Sep 20199:19 amRNSDirector/PDMR Shareholding
30th Aug 20199:00 amRNSTotal Voting Rights
19th Aug 201911:44 amRNSDirector/PDMR Shareholding
14th Aug 201910:39 amRNSHolding(s) in Company
31st Jul 20199:01 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.